GLIDAPAFLOZIN M 10/1000 is an advanced antidiabetic formulation that combines Dapagliflozin (10 mg) and Metformin Hydrochloride (1000 mg), two well-established agents in type 2 diabetes care. This fixed-dose combination works synergistically to control high blood sugar levels, improve insulin sensitivity, and reduce glucose reabsorption in the kidneys. Designed for adults with type 2 diabetes mellitus, GLIDAPAFLOZIN M 10/1000 not only improves glycemic control but also supports weight management and reduces cardiovascular risk when combined with proper diet and exercise.